Tumor cell-produced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basal-like triple negative breast cancer

Christine Mehner, Alexandra Hockla, Erin Miller, Sophia Ran, Derek C Radisky, Evette S Radisky

Research output: Contribution to journalArticle

126 Citations (Scopus)

Abstract

Matrix metalloproteinases (MMPs) have been implicated in diverse roles in breast cancer development and progression. While many of the different MMPs expressed in breast cancer are produced by stromal cells MMP-9 is produced mainly by the tumor cells themselves. To date, the functional role of tumor cell-produced MMP-9 has remained unclear. Here, we show that human breast cancer cell-produced MMP-9 is specifically required for invasion in cell culture and for pulmonary metastasis in a mouse orthotopic model of basal-like breast cancer. We also find that tumor cell-produced MMP-9 promotes tumor vascularization with only modest impact on primary tumor growth, and that silencing of MMP-9 expression in tumor cells leads to an altered transcriptional program consistent with reversion to a less malignant phenotype. MMP-9 is most highly expressed in human basal-like and triple negative tumors, where our data suggest that it contributes to metastatic progression. Our results suggest that MMP9 may offer a target for anti-metastatic therapies for basal-like triple negative breast cancers, a poor prognosis subtype with few available molecularly targeted therapeutic options.

Original languageEnglish (US)
Pages (from-to)2736-2749
Number of pages14
JournalOncotarget
Volume5
Issue number9
StatePublished - 2014

Fingerprint

Triple Negative Breast Neoplasms
Matrix Metalloproteinase 9
Neoplasm Metastasis
Neoplasms
Breast Neoplasms
Matrix Metalloproteinases
Stromal Cells
Cell Culture Techniques
Phenotype
Lung
Therapeutics
Growth

Keywords

  • Basal-like breast cancer
  • Bioluminescence imaging
  • Invasion
  • Matrix metalloproteinases
  • Metastasis
  • Mouse orthotopic tumor models
  • Triple negative breast cancer

ASJC Scopus subject areas

  • Oncology

Cite this

Tumor cell-produced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basal-like triple negative breast cancer. / Mehner, Christine; Hockla, Alexandra; Miller, Erin; Ran, Sophia; Radisky, Derek C; Radisky, Evette S.

In: Oncotarget, Vol. 5, No. 9, 2014, p. 2736-2749.

Research output: Contribution to journalArticle

@article{0482d834d38544b59147759e4695a4f3,
title = "Tumor cell-produced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basal-like triple negative breast cancer",
abstract = "Matrix metalloproteinases (MMPs) have been implicated in diverse roles in breast cancer development and progression. While many of the different MMPs expressed in breast cancer are produced by stromal cells MMP-9 is produced mainly by the tumor cells themselves. To date, the functional role of tumor cell-produced MMP-9 has remained unclear. Here, we show that human breast cancer cell-produced MMP-9 is specifically required for invasion in cell culture and for pulmonary metastasis in a mouse orthotopic model of basal-like breast cancer. We also find that tumor cell-produced MMP-9 promotes tumor vascularization with only modest impact on primary tumor growth, and that silencing of MMP-9 expression in tumor cells leads to an altered transcriptional program consistent with reversion to a less malignant phenotype. MMP-9 is most highly expressed in human basal-like and triple negative tumors, where our data suggest that it contributes to metastatic progression. Our results suggest that MMP9 may offer a target for anti-metastatic therapies for basal-like triple negative breast cancers, a poor prognosis subtype with few available molecularly targeted therapeutic options.",
keywords = "Basal-like breast cancer, Bioluminescence imaging, Invasion, Matrix metalloproteinases, Metastasis, Mouse orthotopic tumor models, Triple negative breast cancer",
author = "Christine Mehner and Alexandra Hockla and Erin Miller and Sophia Ran and Radisky, {Derek C} and Radisky, {Evette S}",
year = "2014",
language = "English (US)",
volume = "5",
pages = "2736--2749",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "9",

}

TY - JOUR

T1 - Tumor cell-produced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basal-like triple negative breast cancer

AU - Mehner, Christine

AU - Hockla, Alexandra

AU - Miller, Erin

AU - Ran, Sophia

AU - Radisky, Derek C

AU - Radisky, Evette S

PY - 2014

Y1 - 2014

N2 - Matrix metalloproteinases (MMPs) have been implicated in diverse roles in breast cancer development and progression. While many of the different MMPs expressed in breast cancer are produced by stromal cells MMP-9 is produced mainly by the tumor cells themselves. To date, the functional role of tumor cell-produced MMP-9 has remained unclear. Here, we show that human breast cancer cell-produced MMP-9 is specifically required for invasion in cell culture and for pulmonary metastasis in a mouse orthotopic model of basal-like breast cancer. We also find that tumor cell-produced MMP-9 promotes tumor vascularization with only modest impact on primary tumor growth, and that silencing of MMP-9 expression in tumor cells leads to an altered transcriptional program consistent with reversion to a less malignant phenotype. MMP-9 is most highly expressed in human basal-like and triple negative tumors, where our data suggest that it contributes to metastatic progression. Our results suggest that MMP9 may offer a target for anti-metastatic therapies for basal-like triple negative breast cancers, a poor prognosis subtype with few available molecularly targeted therapeutic options.

AB - Matrix metalloproteinases (MMPs) have been implicated in diverse roles in breast cancer development and progression. While many of the different MMPs expressed in breast cancer are produced by stromal cells MMP-9 is produced mainly by the tumor cells themselves. To date, the functional role of tumor cell-produced MMP-9 has remained unclear. Here, we show that human breast cancer cell-produced MMP-9 is specifically required for invasion in cell culture and for pulmonary metastasis in a mouse orthotopic model of basal-like breast cancer. We also find that tumor cell-produced MMP-9 promotes tumor vascularization with only modest impact on primary tumor growth, and that silencing of MMP-9 expression in tumor cells leads to an altered transcriptional program consistent with reversion to a less malignant phenotype. MMP-9 is most highly expressed in human basal-like and triple negative tumors, where our data suggest that it contributes to metastatic progression. Our results suggest that MMP9 may offer a target for anti-metastatic therapies for basal-like triple negative breast cancers, a poor prognosis subtype with few available molecularly targeted therapeutic options.

KW - Basal-like breast cancer

KW - Bioluminescence imaging

KW - Invasion

KW - Matrix metalloproteinases

KW - Metastasis

KW - Mouse orthotopic tumor models

KW - Triple negative breast cancer

UR - http://www.scopus.com/inward/record.url?scp=84901191680&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901191680&partnerID=8YFLogxK

M3 - Article

C2 - 24811362

AN - SCOPUS:84901191680

VL - 5

SP - 2736

EP - 2749

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 9

ER -